Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1650 of 2228 entries
View as:

Safety, Tolerability, Pharmacokinetics and Early Pharmacodynamics of Single Rising Oral Doses of BI 1021958 Tablets in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01541488 Org: User:
Start: 02/29/12 End: - Due: -

An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options

Phase: N/A Priority: Normal
NCT ID: NCT05200247 Org: User:
Start: 02/17/22 End: 03/20/23 Due: 03/20/24

The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02172339 Org: User:
Start: 04/30/98 End: - Due: -

A Study That Looks at the Function of the Heart in Patients With Heart Failure Who Take Empagliflozin

Phase: N/A Priority: Normal
NCT ID: NCT03332212 Org: User:
Start: 03/01/18 End: 05/28/20 Due: 05/28/21

Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02265640 Org: User:
Start: 10/31/00 End: - Due: -

This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03210272 Org: User:
Start: 07/18/17 End: 02/18/19 Due: 02/18/20

Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02173652 Org: User:
Start: 03/31/08 End: - Due: -

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

Phase: N/A Priority: Normal
NCT ID: NCT00680186 Org: User:
Start: 04/30/08 End: - Due: -

Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183363 Org: User:
Start: 02/28/07 End: - Due: -

Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02264093 Org: User:
Start: 11/30/99 End: - Due: -

The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids.

Phase: N/A Priority: Normal
NCT ID: NCT03611777 Org: User:
Start: 08/14/18 End: 01/31/20 Due: 01/31/21

Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02028767 Org: User:
Start: 01/31/14 End: 02/28/14 Due: 02/28/15

Tolerability of Asasantin in Healthy Female and Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02269228 Org: User:
Start: 02/29/00 End: - Due: -

Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02173678 Org: User:
Start: 10/31/99 End: - Due: -

A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

Phase: N/A Priority: Normal
NCT ID: NCT05321082 Org: User:
Start: 11/16/22 End: 04/14/25 Due: 04/14/26

Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

Phase: N/A Priority: Normal
NCT ID: NCT05882071 Org: User:
Start: 11/15/23 End: 07/31/26 Due: 07/31/27

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02821910 Org: User:
Start: 07/20/16 End: 10/31/16 Due: 10/31/17

Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259790 Org: User:
Start: 07/31/07 End: - Due: -

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1810631 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05833139 Org: User:
Start: 04/14/23 End: 06/12/23 Due: 06/12/24

Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database

Phase: N/A Priority: Normal
NCT ID: NCT04903496 Org: User:
Start: 09/06/21 End: 06/24/22 Due: 06/24/23

Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients

Phase: N/A Priority: Normal
NCT ID: NCT01853839 Org: User:
Start: 10/31/11 End: 07/31/14 Due: 07/31/15

Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together

Phase: N/A Priority: Normal
NCT ID: NCT01811953 Org: User:
Start: 03/31/13 End: 05/31/13 Due: 05/31/14

Efficacy and Safety of Metamizole Versus Placebo as Antithermic Therapy in the Acute Phase of Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02184260 Org: User:
Start: 12/31/98 End: - Due: -

Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02184052 Org: User:
Start: 07/31/03 End: - Due: -

Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02199873 Org: User:
Start: 06/30/98 End: - Due: -